Todd Harris, President and CEO at Tyra Biosciences, Inc. (TYRA), sold 125,440 shares at $28.16 ($3.4M) on 2024-10-21, disclosed to the SEC on 2024-10-22.
Scheduled sale ($3.4M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.01 | 43,636 | $1.2M | 34.4% |
| 2 | $27.01 | 43,636 | $1.2M | 34.4% |
| 3 | $27.32 | 5,896 | $161K | 4.7% |
| 4 | $27.32 | 5,896 | $161K | 4.7% |
| 5 | $28.16 | 13,188 | $371K | 10.9% |
| 6 | $28.16 | 13,188 |
| $371K |
| 10.9% |
| Total | $27.28 avg | 125,440 | $3.4M | 100% |
| Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |
| TYRA | SELL | 2024-02-06 | $3.3M | — | Filing → |